| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/29/2005 | CN1631394A Dripping pills of isatis root |
| 06/29/2005 | CN1631393A Tablet of isatis root |
| 06/29/2005 | CN1631392A Tablet for treating viral cold |
| 06/29/2005 | CN1631390A Dripping pills for treating viral cold |
| 06/29/2005 | CN1631371A Oral administered bitter free powder of macrolide antibiotic, its prescription and preparation process |
| 06/29/2005 | CN1631369A Cream for treating skin disease |
| 06/29/2005 | CN1631365A Sodium salinomycin powder and its preparation |
| 06/29/2005 | CN1631358A Compound pseudoephedrine hydrochloric acid containing powder for treating cold, its prescription and preparation method |
| 06/29/2005 | CN1208450C Method for the purification, recovery, and sporulation of cysts and oocysts |
| 06/29/2005 | CN1208343C Trichosanthin mutant |
| 06/29/2005 | CN1208336C Tert-butyl-(7-methyl-imidazo [1, 2-a] pyridine-3-yl)-amine derivatives |
| 06/29/2005 | CN1208333C Indole derivatives useful for the treatment of osteoporosis |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208322C Dihydroindole and tetrahydroquinoline derivatives |
| 06/29/2005 | CN1208086C Reptile phrynosoma tablet for treating pulmonary disease |
| 06/29/2005 | CN1208084C Proprietary Chineae traditional medicine for curing chronix virus B hepatitis and its preparation method |
| 06/29/2005 | CN1208083C Chinese traditional medicine composition curing viscera inflammation, toxin and endocrine disorder |
| 06/29/2005 | CN1208078C Medicine for treating bone tuberculosis |
| 06/29/2005 | CN1208077C Medicinal composition for preventing mycotic infection of AIDS patient and use thereof |
| 06/29/2005 | CN1208074C Externally used Chinese medicinal preparation for treating gynaecology disease of cervicitis |
| 06/29/2005 | CN1208073C Ointment for treating various skin diseases and preparation method thereof |
| 06/29/2005 | CN1208065C Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs |
| 06/29/2005 | CN1208063C Medicine composition for treating cold |
| 06/29/2005 | CN1208060C Compound of ceferamet used for injection |
| 06/29/2005 | CN1208058C Oxazolidinone tablet formulation |
| 06/29/2005 | CN1208047C Self-emulsifying formulation for lipophilic compounds |
| 06/28/2005 | US6911526 Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof |
| 06/28/2005 | US6911525 Lipopeptides as antibacterial agents |
| 06/28/2005 | US6911524 Antimicrobial peptides derived from mollusks |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911442 Has no toxicological effects; adapted for oral, topical or parenteral use and may be used for the treatment of bacterial infection in mammals |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911428 Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/28/2005 | US6911424 2′-fluoronucleosides |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/28/2005 | US6911206 Fusion proteins comprising carriers that can induce a dual immune response |
| 06/28/2005 | US6911199 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/28/2005 | CA2271196C Pharmaceutical compositions of hiv protease inhibitors with improved oral bioavailability |
| 06/28/2005 | CA2232230C Phosphopantetheinyl transferases and uses thereof |
| 06/24/2005 | CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/23/2005 | WO2005056792A1 Long double-stranded rna for interference with lowered interferon response |
| 06/23/2005 | WO2005037272A8 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 06/23/2005 | WO2004028564A8 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 06/23/2005 | US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic |
| 06/23/2005 | US20050137237 Triazolo-epothilones |
| 06/23/2005 | US20050137214 Inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 06/23/2005 | US20050137199 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 06/23/2005 | US20050137189 For therapy of Gram-positive bacterial infection |
| 06/23/2005 | US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals |
| 06/23/2005 | US20050137161 Methods and compositions for treating hepatitis C virus |
| 06/23/2005 | US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis |
| 06/23/2005 | US20050137131 UspA1 and UspA2 antigens of Moraxella catarrhalis |
| 06/23/2005 | US20050136074 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 06/23/2005 | US20050136069 Immunogenic portion of Mycobacterium tuberculosis proteins and monophosphoryl lipid A as adjuvant; vaccines |
| 06/23/2005 | US20050136068 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus |
| 06/23/2005 | US20050136067 Multimeric hybrid gene having a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen, especially coding for a parainfluenza virus and a respiratory syncytial virus; vaccines |
| 06/23/2005 | CA2548443A1 Use of chp as an inhibitor of glutathione s-transferases and collagen iv |
| 06/23/2005 | CA2548140A1 Oligosaccharide compositions and use thereof in the treatment of infection |
| 06/23/2005 | CA2547404A1 Compositions comprising an hiv protease inhibitor |
| 06/23/2005 | CA2546895A1 Oxazole derivatives of tetracyclines |
| 06/23/2005 | CA2546769A1 Production of diphtheria toxin |
| 06/23/2005 | CA2544018A1 Compositions and methods to reduce mutagenesis |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544214A1 Non-neutralizing anti-apc antibodies |
| 06/22/2005 | EP1544199A1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor |
| 06/22/2005 | EP1543840A1 Drug absorbability improving agents |
| 06/22/2005 | EP1543838A1 Feline infectious peritonitis vaccine |
| 06/22/2005 | EP1543833A1 Phosphorylated dextran |
| 06/22/2005 | EP1543830A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 06/22/2005 | EP1543829A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 06/22/2005 | EP1543169A2 Method for determining sensitivity to a bacteriophage |
| 06/22/2005 | EP1543165A2 Assays for assembly of ebola virus nucleocapsids |
| 06/22/2005 | EP1543113A1 Chicken astrovirus type 2 |
| 06/22/2005 | EP1543017A2 Bifunctional heterocyclic compounds and methods of making and using same |
| 06/22/2005 | EP1543016A1 The present invention relates to the new 3-decladinosyl derivatives of 9-deoxo-9a-aza-9a-homoerythromycin a 9a,11-cyclic carbamates |
| 06/22/2005 | EP1543006A1 Non-nucleoside reverse transcriptase inhibitors |
| 06/22/2005 | EP1543003A2 Imidazo[1,2-a]pyridines |
| 06/22/2005 | EP1543002A1 Preparation of 1h-imidazo 4,5-c]quinolin-4-amines via1h-imidazo 4,5-c]quinolin-4-phthalimide intermediates |
| 06/22/2005 | EP1542988A1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542728A1 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 06/22/2005 | EP1542721A1 Modified "s" antibodies |
| 06/22/2005 | EP1542718A2 Peptide derivative fusion inhibitors of hiv infection |
| 06/22/2005 | EP1542717A1 Improvements in or relating to vaccines |
| 06/22/2005 | EP1542696A1 Oxazolidinone derivatives as antimicrobials |
| 06/22/2005 | EP1542681A2 Use of posaconazole for the treatment of fungal infections |
| 06/22/2005 | EP1542679A1 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv |
| 06/22/2005 | EP1542671A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 06/22/2005 | EP1381611B1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders |
| 06/22/2005 | EP1177200B1 Ligands for metabotropic glutamate receptors |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1131039B1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 06/22/2005 | EP1124849B1 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 06/22/2005 | EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | EP1040111B1 Integrin receptor antagonists |